Roche facility
This article was originally published in The Tan Sheet
Executive Summary
New biotech center in Grenzach, Germany "will develop biotechnological production processes" for vitamins, carotenoids, new products and "perform scale-up of processes from laboratory to full technical scale," Vitamins & Fine Chemicals division says Nov. 15. Facility "will also provide the necessary data for the construction of production plants as well as for the successful implementation of the processes," Roche notes. Biotech center joins facility in Kaiseraugst, Switzerland; proximity of operations is cited as "key advantage" for company to remain cost leader. Roche announced plans to divest Vitamins & Fine Chemicals unit to DSM in September (1"The Tan Sheet" Sept. 9, 2002, p. 6)...
|
New biotech center in Grenzach, Germany "will develop biotechnological production processes" for vitamins, carotenoids, new products and "perform scale-up of processes from laboratory to full technical scale," Vitamins & Fine Chemicals division says Nov. 15. Facility "will also provide the necessary data for the construction of production plants as well as for the successful implementation of the processes," Roche notes. Biotech center joins facility in Kaiseraugst, Switzerland; proximity of operations is cited as "key advantage" for company to remain cost leader. Roche announced plans to divest Vitamins & Fine Chemicals unit to DSM in September (1 (Also see "DSM To Acquire Leading Position In Vitamin Supply Market With Roche Deal" - Pink Sheet, 9 Sep, 2002.), p. 6).... |